Constant Therapeutics
PrivateLast Round
Grant
Feb 28, 2019
Total Funding Raised
$2.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Constant Therapeutics is a biopharmaceutical company developing proprietary peptides and small molecules for the treatment of stroke recovery, rare neuromuscular disorders, and connective tissue diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Constant Therapeutics Comparables
Compare Constant Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProNeurogen, Inc. | 89% | |
| US Biotest, Inc. | 81% | |
| Alevian, Inc. | 76% |
Constant Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 28, 2019 |
Constant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EB Research Partnership | Grant |
| LifeArc | Grant |
| DEBRA Research gGmbH | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 145% MoM, reaching 4K.
- Jun 16, 2026
Monthly visitors grew 96% MoM.
Constant Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Constant Therapeutics's valuation, stock price, and market status.
Is Constant Therapeutics a public or private company?
Constant Therapeutics is a private company.
What is the current stock price of Constant Therapeutics?
Constant Therapeutics is a private company with no public stock price. Caplight tracks Constant Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Constant Therapeutics worth (valuation)?
Valuation information for Constant Therapeutics is not publicly available.
Can I buy Constant Therapeutics stock?
Constant Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Constant Therapeutics's last funding round?
Constant Therapeutics's most recent funding round was Grant on February 28, 2019.
Who are the main investors in Constant Therapeutics?
Key investors in Constant Therapeutics include EB Research Partnership, LifeArc, DEBRA Research gGmbH.
Will Constant Therapeutics IPO soon?
No public IPO plans have been announced for Constant Therapeutics.
How can I track Constant Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Constant Therapeutics's secondary market activity and sign up for updates.